• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, August 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

High cost of re-operation after breast-conserving surgery

Bioengineer by Bioengineer
December 19, 2018
in Cancer
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A small number of women require re-operation after breast-conserving surgery (BCS) for breast cancer, if the surgical margins are not free from cancer.

A new BJS (British Journal of Surgery) analysis reveals the expense of re-operation. If re-operation rates can be minimized, there may be considerable efficiency savings.

Using data from relevant published studies, the authors found the median hospital costs of women who needed re-operation were £4,511, £2,136 more than in women whose surgical margins were clear.

If these cost estimates are applied nationally, they provide compelling encouragement to seek interventions to minimize re-operation after BCS, which would reduce associated costs.

###

Media Contact
Josh Glickman
[email protected]
http://dx.doi.org/10.1002/bjs.11050

Tags: Breast CancerMedicine/HealthPublic HealthSurgery
Share12Tweet8Share2ShareShareShare2

Related Posts

Study: Traditional prostate cancer risks don’t predict hormone therapy benefit

August 11, 2026

AI Reveals NDRG1-Linked DNA Repair and Synthetic Lethality in Colorectal Cancer

August 10, 2026

Trk and IGF1R Signaling Linked to Delayed Ewing Sarcoma Growth

August 10, 2026

UChicago Medicine Cancer Center and Lilly Partner to Expand Clinical Trial Access

August 10, 2026
Please login to join discussion

POPULAR NEWS

  • How Cells End Gene Transcription Across Coding and Noncoding Genome Regions

    29 shares
    Share 12 Tweet 7
  • Constructing Digital Twin Brains Beyond Measurement Limits

    29 shares
    Share 12 Tweet 7
  • Brewery-waste biochar could trap harmful bacteria in sandy water filters

    29 shares
    Share 12 Tweet 7
  • Study: Traditional prostate cancer risks don’t predict hormone therapy benefit

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

How Cells End Gene Transcription Across Coding and Noncoding Genome Regions

Constructing Digital Twin Brains Beyond Measurement Limits

Brewery-waste biochar could trap harmful bacteria in sandy water filters

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.